Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | histamine receptor H3 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1622 | 0.1622 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1622 | 0.1622 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0128 | 0.6453 | 0.6453 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1622 | 0.1622 |
Schistosoma mansoni | hypothetical protein | 0.0076 | 0.3222 | 0.3222 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.6453 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0076 | 0.3222 | 0.3222 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1815 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0053 | 0.1815 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0053 | 0.1815 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0076 | 0.3222 | 0.3222 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0076 | 0.3222 | 0.3222 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1622 | 0.1622 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1622 | 0.1622 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0128 | 0.6453 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1622 | 0.1622 |
Brugia malayi | hypothetical protein | 0.0076 | 0.3222 | 1 |
Brugia malayi | hypothetical protein | 0.0053 | 0.1815 | 0.4534 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0053 | 0.1815 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0053 | 0.1815 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0053 | 0.1815 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0128 | 0.6453 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0076 | 0.3222 | 0.5 |
Echinococcus multilocularis | geminin | 0.0185 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0076 | 0.3222 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.1622 | 0.3781 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0128 | 0.6453 | 0.6453 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.6453 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0053 | 0.1815 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0128 | 0.6453 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0076 | 0.3222 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0076 | 0.3222 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1622 | 0.1622 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | Inhibition of human ERG | ChEMBL. | 20843691 | |
Kd (functional) | = 9.6 | Antagonist activity against human histamine H3 receptor | ChEMBL. | 20843691 |
Ki (binding) | = 2.1 nM | Displacement of [125I]iodoproxyfan from human recombinant histamine H3 receptor expressed in human SK-N-MC cells after 1 hr by fluid scintillation counting | ChEMBL. | 20843691 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.